These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 25412314)

  • 1. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
    Babcook MA; Sramkoski RM; Fujioka H; Daneshgari F; Almasan A; Shukla S; Nanavaty RR; Gupta S
    Cell Death Dis; 2014 Nov; 5(11):e1536. PubMed ID: 25412314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.
    Babcook MA; Shukla S; Fu P; Vazquez EJ; Puchowicz MA; Molter JP; Oak CZ; MacLennan GT; Flask CA; Lindner DJ; Parker Y; Daneshgari F; Gupta S
    Mol Cancer Ther; 2014 Oct; 13(10):2288-302. PubMed ID: 25122066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
    Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
    Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.
    Nguyen HG; Yang JC; Kung HJ; Shi XB; Tilki D; Lara PN; DeVere White RW; Gao AC; Evans CP
    Oncogene; 2014 Sep; 33(36):4521-30. PubMed ID: 24662833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines.
    Pennanen P; Syvälä H; Bläuer M; Savinainen K; Ylikomi T; Tammela TLJ; Murtola TJ
    Eur J Pharmacol; 2016 Oct; 788():160-167. PubMed ID: 27341997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer.
    Sarveswaran S; Ghosh R; Morisetty S; Ghosh J
    PLoS One; 2015; 10(4):e0122805. PubMed ID: 25875826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
    Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
    Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.
    Chen L; Ahmad N; Liu X
    Cell Cycle; 2016; 15(6):840-9. PubMed ID: 26900800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
    Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
    Lin JZ; Wang WW; Hu TT; Zhu GY; Li LN; Zhang CY; Xu Z; Yu HB; Wu HF; Zhu JG
    Cancer Lett; 2020 Jan; 469():481-489. PubMed ID: 31738958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin induces G
    Chen MJ; Cheng AC; Lee MF; Hsu YC
    J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
    Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
    Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G
    Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin mediates cardioprotection against aging-induced ischemic necroptosis.
    Li C; Mu N; Gu C; Liu M; Yang Z; Yin Y; Chen M; Wang Y; Han Y; Yu L; Ma H
    Aging Cell; 2020 Feb; 19(2):e13096. PubMed ID: 31944526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells.
    Kim Y; Jeong IG; You D; Song SH; Suh N; Jang SW; Kim S; Hwang JJ; Kim CS
    Anticancer Drugs; 2014 Jan; 25(1):53-62. PubMed ID: 24100277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis.
    Liu S; Li Y; Choi HMC; Sarkar C; Koh EY; Wu J; Lipinski MM
    Cell Death Dis; 2018 May; 9(5):476. PubMed ID: 29686269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.